420 related articles for article (PubMed ID: 15367052)
1. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
Misri S; Reebye P; Corral M; Milis L
J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
[TBL] [Abstract][Full Text] [Related]
2. Reexamining paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety.
McClendon J
J Clin Psychiatry; 2005 Nov; 66(11):1494-5; author reply 1495. PubMed ID: 16420094
[No Abstract] [Full Text] [Related]
3. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
4. Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.
Pini S; Amador XF; Dell'Osso L; Baldini Rossi N; Cassano P; Savino M; Cassano GB
Int Clin Psychopharmacol; 2003 Jan; 18(1):15-21. PubMed ID: 12490770
[TBL] [Abstract][Full Text] [Related]
5. Remission rates in patients with anxiety disorders treated with paroxetine.
Ballenger JC
J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
Yonkers KA; Lin H; Howell HB; Heath AC; Cohen LS
J Clin Psychiatry; 2008 Apr; 69(4):659-65. PubMed ID: 18363420
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
9. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine.
Spinhoven P; Van der Does AJ; Van Dijk E; Van Rood YR
J Psychosom Res; 2010 Sep; 69(3):227-35. PubMed ID: 20708444
[TBL] [Abstract][Full Text] [Related]
10. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
Rosenthal M
J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
Yu YM; Gao KR; Yu H; Shen YF; Li HF
J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
[TBL] [Abstract][Full Text] [Related]
12. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
[TBL] [Abstract][Full Text] [Related]
16. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
Rickels K; Rynn M; Iyengar M; Duff D
J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
[TBL] [Abstract][Full Text] [Related]
17. Personality change during depression treatment: a placebo-controlled trial.
Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
[TBL] [Abstract][Full Text] [Related]
18. Internet and Face-to-face Cognitive Behavioral Therapy for Postnatal Depression Compared With Treatment as Usual: Randomized Controlled Trial of MumMoodBooster.
Milgrom J; Danaher BG; Seeley JR; Holt CJ; Holt C; Ericksen J; Tyler MS; Gau JM; Gemmill AW
J Med Internet Res; 2021 Dec; 23(12):e17185. PubMed ID: 34889742
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
[TBL] [Abstract][Full Text] [Related]
20. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
